Benutzerspezifische Werkzeuge

Information zum Seitenaufbau und Sprungmarken fuer Screenreader-Benutzer: Ganz oben links auf jeder Seite befindet sich das Logo der JLU, verlinkt mit der Startseite. Neben dem Logo kann sich rechts daneben das Bannerbild anschließen. Rechts daneben kann sich ein weiteres Bild/Schriftzug befinden. Es folgt die Suche. Unterhalb dieser oberen Leiste schliesst sich die Hauptnavigation an. Unterhalb der Hauptnavigation befindet sich der Inhaltsbereich. Die Feinnavigation findet sich - sofern vorhanden - in der linken Spalte. In der rechten Spalte finden Sie ueblicherweise Kontaktdaten. Als Abschluss der Seite findet sich die Brotkrumennavigation und im Fussbereich Links zu Barrierefreiheit, Impressum, Hilfe und das Login fuer Redakteure. Barrierefreiheit JLU - Logo, Link zur Startseite der JLU-Gießen Direkt zur Navigation vertikale linke Navigationsleiste vor Sie sind hier Direkt zum Inhalt vor rechter Kolumne mit zusaetzlichen Informationen vor Suche vor Fußbereich mit Impressum


Artikelaktionen

Research Details, Wende

Highly specific tailor-made nucleases as essential tools for genome engineering

Highly specific tailor-made nucleases as essential tools for genome engineering

 

After the discovery of the DNA as the molecule carrying the hereditary information of all living organisms, DNA processing enzymes, in particular restriction endonucleases, led to the development of the recombinant DNA technology [1]. Today, in the post-genomic era, a steadily growing number of entire genome sequences is available. The emerging genome editing and genome reprogramming technologies require more sophisticated tools with very high specificity, ideally targeting a unique sequence in a complex genome [2]. Both technologies are highly innovative and have numerous applications in basic science, biotechnology and medicine. These days, transcription activator like effector (TALE) nucleases and the recently introduced CRISPR-Cas9 system have widely spread and become the methods of choice for precision genome engineering [3].

Wolle_fig2

TALE nucleases consist of a TALE repeat array as DNA-binding module and the non-specific DNA-cleavage domain of the restriction endonuclease FokI as DNA-cleavage module. Because the FokI-cleavage domain itself has no further sequence specificity, off-target cleavage may occur [4]. Our group introduced an alternative design, namely to generate chimeras of a DNA recognition element (Zinc fingers or TALE arrays) and a specific restriction endonucleases such as PvuII, which showed a higher specificity in vitro [5-7]. These designer nucleases introduce a highly specific double-strand break in the genome that is either processed by homology-directed repair in the presence of a homologous repair template or by non-homologous end-joining (NHEJ) that usually results in insertions or deletions. The error-prone NHEJ can be efficiently suppressed by ‘nickases’ that produce a single-strand break rather than a double-strand break. We therefore developed a programmable site- and strand-specific nickase, by fusing a TALE array to the DNA mismatch repair protein MutH [8].

Wolle_fig1

The great application potential of artificial genome targeting tools like zinc fingers, TAL effectors and CRISPR-Cas9 systems has been widely acknowledged, however, critical mechanistic details of the technologies remain largely unknown. Therefore, we now investigate the mechanism how these genome targeting tools find their specific target, as well as the thermodynamics and kinetics of DNA binding. Based on these results, we want to improve the specificity of our new designer nucleases and promote their clinical and biotechnological application.

 

1.  Pingoud, A., Wilson, G. G. & Wende, W. (2014) Type II restriction endonucleases—a historical perspective and more, Nucleic Acids Res. 42, 7489-7527.

2.  Pingoud, A. & Wende, W. (2011) Generation of novel nucleases with extended specificity by rational and combinatorial strategies, Chembiochem. 12, 1495-500.

3.  Kim, H. & Kim, J.-S. (2014) A guide to genome engineering with programmable nucleases, Nat Rev Genet. 15, 321-334.

4.  Gabriel, R., Lombardo, A., Arens, A., Miller, J. C., Genovese, P., Kaeppel, C., Nowrouzi, A., Bartholomae, C. C., Wang, J., Friedman, G., Holmes, M. C., Gregory, P. D., Glimm, H., Schmidt, M., Naldini, L. & von Kalle, C. (2011) An unbiased genome-wide analysis of zinc-finger nuclease specificity, Nat Biotechnol. 29, 816-23.

5.  Yanik, M., Alzubi, J., Lahaye, T., Cathomen, T., Pingoud, A. & Wende, W. (2013) TALE-PvuII Fusion Proteins - Novel Tools for Gene Targeting, PLoS One. 8, e82539.

6.  Schierling, B., Dannemann, N., Gabsalilow, L., Wende, W., Cathomen, T. & Pingoud, A. (2012) A novel zinc-finger nuclease platform with a sequence-specific cleavage module, Nucleic Acids Res. 40, 2623-38.

7.  Fonfara, I., Curth, U., Pingoud, A. & Wende, W. (2012) Creating highly specific nucleases by fusion of active restriction endonucleases and catalytically inactive homing endonucleases, Nucleic Acids Res. 40, 847-60.

8.  Gabsalilow, L., Schierling, B., Friedhoff, P., Pingoud, A. & Wende, W. (2013) Site- and strand-specific nicking of DNA by fusion proteins derived from MutH and I-SceI or TALE repeats, Nucleic Acids Res. 41, e83.

 

Selected Publications of the last 5 years

Selected Publications of the last 5 years

 

3.  Yanik, M., Alzubi, J., Lahaye, T., Cathomen, T., Pingoud, A. and Wende, W. (2013) TALE-PvuII fusion proteins – novel tools for gene targeting. PLoS One 8, e82539.

4.  Heller, I., Sitters, G., Broekmans, O. D., Farge, G., Menges, C., Wende, W., Hell, S. W., Peterman, E. J. & Wuite, G. J. (2013). STED nanoscopy combined with optical tweezers reveals protein dynamics on densely covered DNA. Nature Methods 10, 910-916.

5.  Gabsalilow, L., Schierling, B., Friedhoff, P., Pingoud, A. and Wende, W. (2013) Site- and strand-specific nicking of DNA by fusion proteins derived from MutH and I-SceI or TALE repeats. Nucleic Acids Res., 41, e83.

Collaboration partners (alphabetic order)

Collaboration partners (alphabetic order)

 

Toni Cathomen, University Medical Center Freiburg, Germany

Thomas Lahaye, ZMBP – University of Tuebingen, Germany

Michael Kokkinidis, University of Crete, Heraklion, Greece

Elena Kubareva / Tatjana Oretskaya, Moscow State University, Russia

Ralf Seidel, University Leipzig, Germany

Knut Stieger, retinale Gentherapie - UKGM, Gießen, Germany

Gijs Wuite, VU University Amsterdam, Netherlands